These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25108556)

  • 21. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499.
    Byun SY; Shin YJ; Nam KY; Hong SP; Ahn SK
    Life Sci; 2015 Jan; 120():1-7. PubMed ID: 25447448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of methoxychlor and its metabolite 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane on 11β-hydroxysteroid dehydrogenase activities in vitro.
    Guo J; Deng H; Li H; Zhu Q; Zhao B; Chen B; Chu Y; Ge RS
    Toxicol Lett; 2013 Mar; 218(1):18-23. PubMed ID: 23333641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid hepatic metabolism of 7-ketocholesterol by 11beta-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzyme.
    Schweizer RA; Zürcher M; Balazs Z; Dick B; Odermatt A
    J Biol Chem; 2004 Apr; 279(18):18415-24. PubMed ID: 14973125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early morphologic and enzymatic changes in livers of rats treated with chenodeoxycholic and ursodeoxycholic acids.
    Shefer S; Zaki FG; Salen G
    Hepatology; 1983; 3(2):201-8. PubMed ID: 6832710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and 11β hydroxysteroid dehydrogenase 1 inhibition of thiazolidine derivatives with an adamantyl group.
    Kwon SW; Kang SK; Lee JH; Bok JH; Kim CH; Dal Rhee S; Jung WH; Kim HY; Bae MA; Song JS; Ha DC; Cheon HG; Kim KY; Ahn JH
    Bioorg Med Chem Lett; 2011 Jan; 21(1):435-9. PubMed ID: 21093259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of bile acid depletion and of ursodeoxycholic and chenodeoxycholic acids on biliary protein secretion in the hamster.
    Malavolti M; Fromm H; Ceryak S; Shehan KL
    Life Sci; 1990; 46(23):1727-37. PubMed ID: 2355803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mutagenicity of bile acids using a fluctuation test.
    Watabe J; Bernstein H
    Mutat Res; 1985; 158(1-2):45-51. PubMed ID: 2995801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: possible contribution of 11β-hydroxysteroid dehydrogenase type 1 inhibition in rodent adipose tissue.
    Tagawa N; Minamitani E; Yamaguchi Y; Kobayashi Y
    Steroids; 2011 Dec; 76(14):1546-53. PubMed ID: 21945397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 11β-Hydroxysteroid dehydrogenase 1: Regeneration of active glucocorticoids is only part of the story.
    Odermatt A; Klusonova P
    J Steroid Biochem Mol Biol; 2015 Jul; 151():85-92. PubMed ID: 25151952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of adamantyl heterocyclic ketones as potent 11β-hydroxysteroid dehydrogenase type 1 inhibitors.
    Su X; Vicker N; Thomas MP; Pradaux-Caggiano F; Halem H; Culler MD; Potter BV
    ChemMedChem; 2011 Aug; 6(8):1439-51. PubMed ID: 21608132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid.
    Piazza F; Montagnani M; Russo C; Azzaroli F; Aldini R; Roda E; Roda A
    Dig Liver Dis; 2000 May; 32(4):318-28. PubMed ID: 11515630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manifold effects of palmitoylcarnitine on endoplasmic reticulum metabolism: 11β-hydroxysteroid dehydrogenase 1, flux through hexose-6-phosphate dehydrogenase and NADPH concentration.
    Wang X; Mick GJ; Maser E; McCormick K
    Biochem J; 2011 Jul; 437(1):109-15. PubMed ID: 21492096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous inhibition of 11β-hydroxysteroid dehydrogenase type I in adipose tissue leads to tachyphylaxis in humans and rats but not in mice.
    Morentin Gutierrez P; Gyte A; deSchoolmeester J; Ceuppens P; Swales J; Stacey C; Eriksson JW; Sjöstrand M; Nilsson C; Leighton B
    Br J Pharmacol; 2015 Oct; 172(20):4806-16. PubMed ID: 26218540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of 7-ketolithocholic acid on bile acid metabolism in humans.
    Salen G; Verga D; Batta AK; Tint GS; Shefer S
    Gastroenterology; 1982 Aug; 83(2):341-7. PubMed ID: 7084613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of 11β-hydroxysteroid dehydrogenase type 1 ameliorates obesity-related insulin resistance.
    Shao S; Zhang X; Zhang M
    Biochem Biophys Res Commun; 2016 Sep; 478(1):474-480. PubMed ID: 27268236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of microsomal 11beta-HSD1 activity by cytosolic compounds: glutathione and hexose phosphoesters.
    McCormick KL; Wang X; Mick GJ
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):18-23. PubMed ID: 18550363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 17Beta-estradiol inhibits 11beta-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes.
    Tagawa N; Yuda R; Kubota S; Wakabayashi M; Yamaguchi Y; Kiyonaga D; Mori N; Minamitani E; Masuzaki H; Kobayashi Y
    J Endocrinol; 2009 Jul; 202(1):131-9. PubMed ID: 19380458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, INU-101.
    Hong SP; Han D; Chang KH; Ahn SK
    Eur J Pharmacol; 2018 Sep; 835():169-178. PubMed ID: 30096297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.